Treadmill testing improves survival prediction models in pulmonary arterial hypertension
- PMID: 22137074
- DOI: 10.1016/j.ahj.2011.09.015
Treadmill testing improves survival prediction models in pulmonary arterial hypertension
Abstract
Background: Six-minute walk distance (6MWD) is used in the REVEAL equation to predict 1-year survival for patients with pulmonary arterial hypertension. We sought to determine whether exercise treadmill testing (ETT) could be used in its place.
Methods: This was a single-center study in which 449 patients were enrolled. The variables predictive of survival in the REVEAL equation were evaluated and compared with survival predicted by the REVEAL equation without an exercise measure and a revised equation using ETT.
Results: The addition of ETT to the equation improved the predictive ability of the REVEAL equation in the high- and low-risk patient groups.
Conclusion: The study findings suggest that the addition of ETT parameters to the REVEAL prognostic equation improves the predictive value of the equation when 6-minute walk distance is unavailable.
Copyright © 2011 Mosby, Inc. All rights reserved.
Similar articles
-
Exercise testing to estimate survival in pulmonary hypertension.Med Sci Sports Exerc. 2008 Oct;40(10):1725-32. doi: 10.1249/MSS.0b013e31817c92c0. Med Sci Sports Exerc. 2008. PMID: 18799981
-
Value of exercise treadmill testing in the risk stratification of patients with pulmonary hypertension.Circ Heart Fail. 2009 Jul;2(4):278-86. doi: 10.1161/CIRCHEARTFAILURE.108.807826. Epub 2009 May 13. Circ Heart Fail. 2009. PMID: 19808350
-
Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance.J Heart Lung Transplant. 2015 Mar;34(3):362-8. doi: 10.1016/j.healun.2014.08.020. Epub 2014 Aug 28. J Heart Lung Transplant. 2015. PMID: 25312386
-
Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.J Heart Lung Transplant. 2011 Sep;30(9):982-9. doi: 10.1016/j.healun.2011.03.011. Epub 2011 May 4. J Heart Lung Transplant. 2011. PMID: 21531577 Clinical Trial.
-
Prognostication in pulmonary arterial hypertension.Heart Fail Clin. 2012 Jul;8(3):373-83. doi: 10.1016/j.hfc.2012.04.011. Heart Fail Clin. 2012. PMID: 22748900 Review.
Cited by
-
Prognostic Value of Serial Risk Stratification in Adult and Pediatric Pulmonary Arterial Hypertension: A Systematic Review.J Am Heart Assoc. 2024 Jul 2;13(13):e034151. doi: 10.1161/JAHA.123.034151. Epub 2024 Jun 21. J Am Heart Assoc. 2024. PMID: 38904230 Free PMC article.
-
Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation.Eur Respir Rev. 2014 Dec;23(134):488-97. doi: 10.1183/09059180.00007214. Eur Respir Rev. 2014. PMID: 25445947 Free PMC article. Review.
-
Micro-RNA Analysis in Pulmonary Arterial Hypertension: Current Knowledge and Challenges.JACC Basic Transl Sci. 2020 Nov 23;5(11):1149-1162. doi: 10.1016/j.jacbts.2020.07.008. eCollection 2020 Nov. JACC Basic Transl Sci. 2020. PMID: 33294743 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical